Telesis Bio Statistics
Total Valuation
Telesis Bio has a market cap or net worth of 3.01 million. The enterprise value is 58.83 million.
| Market Cap | 3.01M |
| Enterprise Value | 58.83M |
Important Dates
The next estimated earnings date is Friday, November 8, 2024.
| Earnings Date | Nov 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Telesis Bio has 1.77 million shares outstanding. The number of shares has increased by 2.24% in one year.
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | +2.24% |
| Shares Change (QoQ) | +3.54% |
| Owned by Insiders (%) | 20.17% |
| Owned by Institutions (%) | 3.16% |
| Float | 612,106 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.13 |
| EV / Sales | 3.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.58 |
Financial Position
The company has a current ratio of 1.89, with a Debt / Equity ratio of 3.57.
| Current Ratio | 1.89 |
| Quick Ratio | 1.44 |
| Debt / Equity | 3.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.56 |
| Interest Coverage | -16.20 |
Financial Efficiency
Return on equity (ROE) is -147.84% and return on invested capital (ROIC) is -29.41%.
| Return on Equity (ROE) | -147.84% |
| Return on Assets (ROA) | -26.52% |
| Return on Capital (ROIC) | -29.41% |
| Revenue Per Employee | 184,585 |
| Profits Per Employee | -489,321 |
| Employee Count | 147 |
| Asset Turnover | 0.23 |
| Inventory Turnover | 3.85 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -89.07% in the last 52 weeks. The beta is 1.76, so Telesis Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.76 |
| 52-Week Price Change | -89.07% |
| 50-Day Moving Average | 2.86 |
| 200-Day Moving Average | 5.06 |
| Relative Strength Index (RSI) | 35.52 |
| Average Volume (20 Days) | 62,725 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, Telesis Bio had revenue of 19.57 million and -51.87 million in losses. Loss per share was -30.82.
| Revenue | 19.57M |
| Gross Profit | 9.51M |
| Operating Income | -35.48M |
| Pretax Income | -48.78M |
| Net Income | -51.87M |
| EBITDA | -32.89M |
| EBIT | -35.48M |
| Loss Per Share | -30.82 |
Balance Sheet
The company has 10.21 million in cash and 35.55 million in debt, giving a net cash position of -25.34 million or -14.29 per share.
| Cash & Cash Equivalents | 10.21M |
| Total Debt | 35.55M |
| Net Cash | -25.34M |
| Net Cash Per Share | -14.29 |
| Equity (Book Value) | 9.95M |
| Book Value Per Share | -11.59 |
| Working Capital | 7.14M |
Cash Flow
In the last 12 months, operating cash flow was -21.78 million and capital expenditures -1.01 million, giving a free cash flow of -22.79 million.
| Operating Cash Flow | -21.78M |
| Capital Expenditures | -1.01M |
| Free Cash Flow | -22.79M |
| FCF Per Share | -12.86 |
Margins
Gross margin is 48.60%, with operating and profit margins of -181.35% and -253.19%.
| Gross Margin | 48.60% |
| Operating Margin | -181.35% |
| Pretax Margin | -249.29% |
| Profit Margin | -253.19% |
| EBITDA Margin | -168.09% |
| EBIT Margin | -181.35% |
| FCF Margin | -116.50% |
Dividends & Yields
Telesis Bio does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.24% |
| Shareholder Yield | -2.24% |
| Earnings Yield | -1,812.76% |
| FCF Yield | -756.27% |
Stock Splits
The last stock split was on May 9, 2024. It was a reverse split with a ratio of 0.0555556.
| Last Split Date | May 9, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.0555556 |
Scores
Telesis Bio has an Altman Z-Score of -6.26. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.26 |
| Piotroski F-Score | n/a |